2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol

C110H132N16O5 — CID 157364064

IUPAC2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
SMILESCO[C@@H]1CCN(c2ccc3nc(C4CC4)nc(N4CCC(c5ccccc5C)CC4)c3c2)C1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(OC)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](O)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@H](O)C4)cc23)CC1
InChIInChI=1S/C28H34N4O2.C28H34N4O.2C27H32N4O/c1-33-22-13-16-32(18-22)21-9-10-25-24(17-21)28(30-27(29-25)20-7-8-20)31-14-11-19(12-15-31)23-5-3-4-6-26(23)34-2;1-19-5-3-4-6-24(19)20-11-14-31(15-12-20)28-25-17-22(32-16-13-23(18-32)33-2)9-10-26(25)29-27(30-28)21-7-8-21;2*1-18-4-2-3-5-23(18)19-10-13-30(14-11-19)27-24-16-21(31-15-12-22(32)17-31)8-9-25(24)28-26(29-27)20-6-7-20/h3-6,9-10,17,19-20,22H,7-8,11-16,18H2,1-2H3;3-6,9-10,17,20-21,23H,7-8,11-16,18H2,1-2H3;2*2-5,8-9,16,19-20,22,32H,6-7,10-15,17H2,1H3/t;23-;2*22-/m.110/s1
InChIKeyBIYZLUPDLPWYDV-PIOAPSDTSA-N
MW1758.37 g/mol
LogP20.09
Rot. Bonds19

About 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol

2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol (PubChem CID 157364064) has the molecular formula C110H132N16O5 and a molecular weight of 1758.37 g/mol. Its IUPAC name is 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol.

Molecular Properties

Compound Name2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
PubChem CID157364064
Molecular FormulaC110H132N16O5
Molecular Weight1758.37 g/mol
Exact Mass1757.06
IUPAC Name2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol
SMILESCO[C@@H]1CCN(c2ccc3nc(C4CC4)nc(N4CCC(c5ccccc5C)CC4)c3c2)C1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(OC)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](O)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@H](O)C4)cc23)CC1
InChIInChI=1S/C28H34N4O2.C28H34N4O.2C27H32N4O/c1-33-22-13-16-32(18-22)21-9-10-25-24(17-21)28(30-27(29-25)20-7-8-20)31-14-11-19(12-15-31)23-5-3-4-6-26(23)34-2;1-19-5-3-4-6-24(19)20-11-14-31(15-12-20)28-25-17-22(32-16-13-23(18-32)33-2)9-10-26(25)29-27(30-28)21-7-8-21;2*1-18-4-2-3-5-23(18)19-10-13-30(14-11-19)27-24-16-21(31-15-12-22(32)17-31)8-9-25(24)28-26(29-27)20-6-7-20/h3-6,9-10,17,19-20,22H,7-8,11-16,18H2,1-2H3;3-6,9-10,17,20-21,23H,7-8,11-16,18H2,1-2H3;2*2-5,8-9,16,19-20,22,32H,6-7,10-15,17H2,1H3/t;23-;2*22-/m.110/s1
InChIKeyBIYZLUPDLPWYDV-PIOAPSDTSA-N
XLogP20.09
TPSA197.19 Ų
H-Bond Donors2
H-Bond Acceptors21
Rotatable Bonds19
Heavy Atoms131
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001758.37
LogP ≤ 520.09
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1021

Analyze 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
The IUPAC name of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol (CID 157364064) is 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol.
What is the SMILES notation for 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
The canonical SMILES for 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol is CO[C@@H]1CCN(c2ccc3nc(C4CC4)nc(N4CCC(c5ccccc5C)CC4)c3c2)C1.COc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CCC(OC)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@@H](O)C4)cc23)CC1.Cc1ccccc1C1CCN(c2nc(C3CC3)nc3ccc(N4CC[C@H](O)C4)cc23)CC1.
What is the InChIKey of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
The InChIKey is BIYZLUPDLPWYDV-PIOAPSDTSA-N. The full InChI is InChI=1S/C28H34N4O2.C28H34N4O.2C27H32N4O/c1-33-22-13-16-32(18-22)21-9-10-25-24(17-21)28(30-27(29-25)20-7-8-20)31-14-11-19(12-15-31)23-5-3-4-6-26(23)34-2;1-19-5-3-4-6-24(19)20-11-14-31(15-12-20)28-25-17-22(32-16-13-23(18-32)33-2)9-10-26(25)29-27(30-28)21-7-8-21;2*1-18-4-2-3-5-23(18)19-10-13-30(14-11-19)27-24-16-21(31-15-12-22(32)17-31)8-9-25(24)28-26(29-27)20-6-7-20/h3-6,9-10,17,19-20,22H,7-8,11-16,18H2,1-2H3;3-6,9-10,17,20-21,23H,7-8,11-16,18H2,1-2H3;2*2-5,8-9,16,19-20,22,32H,6-7,10-15,17H2,1H3/t;23-;2*22-/m.110/s1.
What are the key properties of 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol?
2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol has a molecular weight of 1758.37 g/mol, XLogP of 20.09, 19 rotatable bonds, 2 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-4-[4-(2-methoxyphenyl)piperidin-1-yl]-6-(3-methoxypyrrolidin-1-yl)quinazoline;2-cyclopropyl-6-[(3R)-3-methoxypyrrolidin-1-yl]-4-[4-(2-methylphenyl)piperidin-1-yl]quinazoline;(3R)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol;(3S)-1-[2-cyclopropyl-4-[4-(2-methylphenyl)piperidin-1-yl]quinazolin-6-yl]pyrrolidin-3-ol is sourced from PubChem (CID 157364064), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).